| __timestamp | Dr. Reddy's Laboratories Limited | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 56369000000 | 241751000 |
| Thursday, January 1, 2015 | 62786000000 | 322292000 |
| Friday, January 1, 2016 | 62427000000 | 344320000 |
| Sunday, January 1, 2017 | 62453000000 | 374644000 |
| Monday, January 1, 2018 | 65724000000 | 1820000 |
| Tuesday, January 1, 2019 | 70421000000 | 4000000 |
| Wednesday, January 1, 2020 | 80591000000 | 12000000 |
| Friday, January 1, 2021 | 86645000000 | 11000000 |
| Saturday, January 1, 2022 | 100551000000 | 14000000 |
| Sunday, January 1, 2023 | 42907000000 | 9133000 |
| Monday, January 1, 2024 | 115557000000 | 11215000 |
Unleashing insights
In the ever-evolving pharmaceutical industry, understanding the cost of revenue is crucial for assessing a company's financial health. Dr. Reddy's Laboratories Limited, a major player in the global market, has shown a consistent upward trend in its cost of revenue from 2014 to 2024. Notably, the cost surged by approximately 105% from 2014 to 2024, reflecting the company's expansion and increased production capabilities.
On the other hand, Ionis Pharmaceuticals, Inc., a leader in RNA-targeted drug discovery, presents a contrasting picture. The company's cost of revenue peaked in 2017 but has since fluctuated, with a significant drop in 2018. This volatility highlights the challenges faced by smaller biotech firms in managing production costs.
The data also reveals missing values for Ionis Pharmaceuticals in 2024, indicating potential reporting gaps or strategic shifts. This analysis underscores the diverse financial landscapes within the pharmaceutical sector.
Cost of Revenue: Key Insights for Novo Nordisk A/S and Dr. Reddy's Laboratories Limited
Cost of Revenue Comparison: Johnson & Johnson vs Dr. Reddy's Laboratories Limited
Comparing Cost of Revenue Efficiency: GSK plc vs Dr. Reddy's Laboratories Limited
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and Dr. Reddy's Laboratories Limited
Biogen Inc. vs Dr. Reddy's Laboratories Limited: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Insmed Incorporated and Ionis Pharmaceuticals, Inc.
Analyzing Cost of Revenue: Dr. Reddy's Laboratories Limited and Bio-Techne Corporation
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs PTC Therapeutics, Inc.
Cost Insights: Breaking Down Dr. Reddy's Laboratories Limited and ACADIA Pharmaceuticals Inc.'s Expenses
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and Dyne Therapeutics, Inc.
Halozyme Therapeutics, Inc. vs Ionis Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Ionis Pharmaceuticals, Inc. vs Perrigo Company plc